You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 301 to 325 of about 6087
Next 25
05/28/2024
Musella Foundation Awards 3 Research Grants!
Brain Tumor Awareness Month Webinar Series
05/27/2024
Can Boosting Hydrogen Sulfide Bolster Standard-of-Care Glioblastoma Therapy to Extend Survival?
Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant improvement in overall survival of newly diagnosed glioblastoma patients
05/23/2024
IMVAX Announces Completion of Enrollment in Phase 2b Clinical Trial of IGV-001 and Successful Financing
President Lech Walesa of Poland Announces Plan to Harness Wind and Solar Energy to Discover Cancer Treatments and Cures
05/21/2024
URGENT - Promising Pathway 2.0!
05/20/2024
Brain Tumor Awareness Month Webinar Today
05/16/2024
Brain Tumor Awareness Month Webinar Tonight
05/13/2024
Musella Foundation Celebrates 26th Anniversary!
05/12/2024
TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II trial
05/06/2024
CIRM Awards $11.8 Million Grant for Clinical Trial in High-Grade Glioma Including Glioblastoma Using DB107, a Novel DGM7 Genetic Biomarker-Guided Gene Therapy
Minnesota Brain Tumor 5k Announces 15th Annul Fun Walk/Run
05/02/2024
04/29/2024
Path forward for glioblastoma treatment
New York Advocacy Alert!
04/28/2024
Results from a first-in-human phase I safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma
FDA approves new drug for pediatric low-grade glioma with BRAF fusions or mutation
04/22/2024
Carthera partners with Agenus and Northwestern University for phase 2a trial combining SonoCloud-9 with checkpoint inhibitors to treat glioblastoma
Urgent funding needed for DIPG sonodynamic therapy trial
Gene Therapy Is Halting Cancer - Can It Work Against Brain Tumors?
ROSALIE Trial of EO2401/Nivolumab/Bevacizumab in Recurrent Glioblastoma Concludes